Trial Profile
Treatment Intensification in HIV-1 Patients With Multi-Drug Resistant Virus
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 16 Sep 2008 Planned end date changed from 1 Mar 2006 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 24 Oct 2005 New trial record.